The FDA-cleared Res-Q technology is a point-of-care platform designed to prepare cell concentrates. Once prepared, the PRP is mixed with autograft or allograft bone prior to application.
Related Articles on Orthopedic Devices:
Ortho Kinematics Receives FDA Clearance on KineGraph Vertebral Motion Analyzer
56 Orthopedic & Spine Devices Receive FDA 510(k) Clearance in December
AAOS Releases Technology Overview for Metal-on-Metal Hip Implants
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
